BRIEF published on 08/30/2024 at 07:05, 1 year 6 months ago Vita 34 AG Sustains Growth in H1 2024, Strongly Boosts Operating Cash Flow Revenue Growth Operating Cash Flow Vita 34 AG EBITDA Increase H1 2024 Results
PRESS RELEASE published on 08/30/2024 at 07:00, 1 year 6 months ago Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow Vita 34 AG reports positive first half of 2024 with revenue growth and increased operating cash flow. EBITDA up by 76.4%. Full-year outlook confirmed EBITDA Revenue Growth Operating Cash Flow Vita 34 AG First Half Results
BRIEF published on 08/09/2024 at 17:09, 1 year 7 months ago Les filiales de Vita 34 concluent un accord avec un concédant de licence américain Vita 34 FamiCordTx PBKM Technologie CAR-T Accord Sur Les Biotechnologies
BRIEF published on 08/09/2024 at 17:09, 1 year 7 months ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
PRESS RELEASE published on 08/09/2024 at 17:04, 1 year 7 months ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
BRIEF published on 08/01/2024 at 12:44, 1 year 7 months ago Thomas Pfaadt nommé nouveau directeur financier de Vita 34 AG Conseil D'administration Finance Vita 34 AG Directeur Financier Thomas Pfaadt
BRIEF published on 08/01/2024 at 12:44, 1 year 7 months ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
PRESS RELEASE published on 08/01/2024 at 12:39, 1 year 7 months ago Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Thomas Pfaadt appointed as new CFO of Vita 34 AG, bringing 20+ years of experience. Management Board complete. Vita 34, leading cell bank in Europe, focusing on cell banking and investments in therapies CFO Vita 34 AG Investments Thomas Pfaadt Cell Banking
PRESS RELEASE published on 06/04/2024 at 18:36, 1 year 9 months ago Original-Research: Vita 34 AG (von Montega AG): Halten Vita 34 AG steigert Umsatz in Q1 um 3,6% auf 18,6 Mio. EUR. Montega AG empfiehlt Halten mit Kursziel 6,00 EUR. Analyse von Tim Kruse (CFA). Lizenzverfahren CAR-T bleibt offen Montega AG Vita 34 AG Umsatzsteigerung Halten Lizenzverfahren CAR-T
BRIEF published on 05/31/2024 at 08:38, 1 year 9 months ago Vita 34 annonce des augmentations significatives de ses bénéfices et de ses flux de trésorerie Hausse Des Revenus BAIIA Résultats Du Premier Trimestre 2024 Vie 34 Flux De Trésorerie Opérationnel
Published on 03/24/2026 at 13:30, 4 hours 40 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 4 hours 40 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 5 hours 35 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 5 hours 37 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 5 hours 40 minutes ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 17:50, 20 minutes ago Annual General Meeting of Bellevue Group AG – all proposals approved
Published on 03/24/2026 at 16:50, 1 hour 20 minutes ago LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds
Published on 03/24/2026 at 16:14, 1 hour 55 minutes ago TenneT Germany receives preliminary inaugural S&P credit rating of BBB+ with stable outlook
